| 期刊論文| 1. | Paul, Steven M.、Mytelka, D. S.、Dunwiddie, C. T.、Persinger, C. C.、Munos, B. H.、Lindborg, S. R.、Schacht, A. L.(2010)。How to improve R&D productivity: The pharmaceutical industry's grand challenge。Nature Reviews Drug Discovery，9(3)，203-214。   | | 2. | Gaudry, Kate S.(2011)。Evergreening: A Common Practice to Protect New Drugs。Nature Biotechnology，29(10)，876-878。 | | 3. | Kapczynski, Amy(2012)。Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of "Secondary" Pharmaceutical Patents。Plos One，7(12)，(e49470)1-(e49470)3。 | | 4. | Berndt, Ernst R.、Mortimer, R.、Bhattacharjya, A.、Parece, A.、Tuttle, E.(2007)。Authorized Generic Drugs, Price Competition, and Consumers' Welfare。Health Affairs，26(3)，790-799。 | | 5. | Eastmanet, Richard T.、Roth, J. S.、Brimacombe, K. R.、Simeonov, A.、Shen, M.、Patnaik, S.、Hall, M. D.(2020)。Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19。ACS Central Science，6，672-674。 | | 6. | Siegel, Dustin(2017)。Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses。J. Med. Chem.，60(5)，1648-1649。 | | 7. | DiMasi, Joseph A.、Grabowski, Henry G.、Hansen, Ronald W.(2016)。Innovation in the pharmaceutical industry: New estimates of R&D costs。Journal of Health Economics，47，20-33。 | 圖書| 1. | Ellery, Tony、Hansen, Neal(2012)。Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand。Wiley。 | | 2. | European Commission(2009)。Pharmaceutical Sector Inquiry-- Final Report。 | | 3. | Griffin, John P.(2013)。The Textbook of Pharmaceutical Medicine。 | 其他| 1. | Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment，https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment。 | | 2. | Development of Remdesivir，https://www.gilead.eom/-/media/gilead-corporate/files/pdfs/covid-19/gilead_rdv-development-fact-sheet-2020.pdf。 | | 3. | Quintilesims Institute(2017)。Lifetime Trends in Biopharmaceutical Innovation: Recent Evidence and Implications。 | 圖書論文| 1. | Cockburn, I. M.(2009)。Intellectual Property Rights and Pharmaceuticals: Challenges and Opportunities for Economic Research。The Economics of Intellectual Property. Suggestions for Further Research in Developing Countries and Countries with Economies in Transition。 | |